Research Studies Begin for mRNA Cancer Immunization

Research using an mRNA vaccination has started at Oxford University Hospitals in Oxford, to treat patients with head and neck cancer. 

The study will recruit individuals diagnosed with advanced or inoperable head and neck malignancies that are also positive for HPV-16. 

mRNA cancer immunizations work by offering a template of cancer cells to the individual’s immune defense, aiding in the rapid recognition and elimination of these cells. 

Dr Lennard Lee, a University of Oxford professor, stated, “The Oxford Cancer Centre at OUH has been very successful in bringing new opportunities for patients and is leading the charge for mRNA cancer vaccine trials.” 

Dr Lee went on to add, “These mRNA cancer vaccines could be the silver lining of recent years, and an amazing tool for those affected by cancer.” 

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.